ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Debt.com poll: We'll Spend More Preparing for Natural Disasters Because of COVID-19
July 21, 2021Americans will spend more preparing for natural disasters in 2021 than they did in 2020, and the reason is simple: COVID-19 showed just how scary life can be when you don't have enough supplies and planning. -
mfine Raises Rs 31 crore in venture debt from Alteria Capital
July 05, 2019mfine, a health-tech AI startup that enables virtual medical consultations, has raised Rs 31 crore as venture debt from Alteria Capital, India’s largest venture debt fund. -
Bionano Genomics enters into debt and equity financing agreements totaling $41.5m in commitments
March 19, 2019The Company intends to use approximately $11 million of the term loan proceeds to terminate its existing debt with Midcap Financial Services, LLC. -
Takeda may sell Shire assets to reduce debt following $62-billion purchase
September 14, 2018According to people close to the situation, Takeda is considering selling Shire's eye-care business, including the dry eye disease treatment Xiidra (lifitegrast)... -
Teva puts Medis—and maybe more—on the block to help ease its debt woes
August 10, 2017Teva has already said it's looking for buyers for its women's health and European oncology and pain businesses.
Pharma Sources Insight January 2025
